With regard to hypertrophy, we observe upregulation of Ca2+/calmodulin-dependent protein kinase (CAMK) and NFAT pathway activity, which are known to act in parallel to induce cardiac hypertrophy [supplementary material Fig. 8(e)].65,66. Here, CA2 is linked to cardiac hypertrophy.